Nab-paclitaxel trials for Stage IV Pancreatic Cancer AJCC v8

All Nab-paclitaxel trials · All Stage IV Pancreatic Cancer AJCC v8 trials

Phase breakdown

Recruiting trials studying Nab-paclitaxel for Stage IV Pancreatic Cancer AJCC v8

• BMS-986340 in Combination With Nivolumab, Gemcitabine and Nab-paclitaxel for the Treatment of Metastatic and Recurrent Pancreatic Adenocarcinoma
  NCT07226856 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
  NCT04858009 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
  NCT06998940 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 274 locations
• Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
  NCT06958328 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 322 locations

Common questions

How many trials study Nab-paclitaxel for Stage IV Pancreatic Cancer AJCC v8?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.